Asarfi Hospital

80.20
-4.47
(-5.28%)
Market Cap
157.80 Cr
EPS
2.31
PE Ratio
40.13
Dividend Yield
0.00 %
52 Week High
111.95
52 Week Low
52.84
PB Ratio
2.37
Debt to Equity
0.45
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,129.40
#1 1,09,792.59
102.90
5,584.10
18.77
#1 1,058
-17.46
59.65
6,492.05
93,345.72
71.54
#1 19,165.50
14.74
917
49.14
54.11
671.80
50,718.09
61.76
6,931.20
8.99
645
#1 89.49
62.72
1,673.40
34,197.74
42.51
5,093.40
10.96
790
2.66
65.20
1,213.85
32,602.48
64.67
2,759.20
#1 25.09
326
15.71
53.06
622.50
24,908.65
70.52
2,511.20
12.94
336
20.76
61.44
453.35
22,645.42
83.71
3,723.70
22.85
205
-69.22
62.46
1,378.50
13,998.90
56.82
1,334.00
10.76
218
10.06
59.81
5,180.00
11,456.25
#1 27.61
599.90
11.69
58
8.85
42.49
1,536.85
10,076.51
57.85
1,095.50
21.32
177
20.14
46.80
Growth Rate
Revenue Growth
17.85 %
Net Income Growth
-47.45 %
Cash Flow Change
3,376.00 %
ROE
-68.78 %
ROCE
-57.58 %
EBITDA Margin (Avg.)
-6.37 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Dec 2024
Revenue
21
24
34
Expenses
16
20
26
EBITDA
5
4
8
Operating Profit %
20 %
16 %
21 %
Depreciation
3
4
3
Interest
1
1
1
Profit Before Tax
1
-1
4
Tax
1
-1
1
Net Profit
-0
-0
3
EPS in ₹
-0.03
0.00
1.36

Balance Sheet

Balance Sheet
2024
Total Assets
154
Fixed Assets
94
Current Assets
47
Capital Work in Progress
0
Investments
0
Other Assets
60
Total Liabilities
154
Current Liabilities
42
Non Current Liabilities
42
Total Equity
70
Reserve & Surplus
51
Share Capital
20

Cash Flow

Cash Flow
2024
Net Cash Flow
-1
Investing Activities
-63
Operating Activities
26
Financing Activities
36

Share Holding

% Holding
Mar 2023
Jul 2023
Sept 2023
Mar 2024
Sept 2024
Promoter
83.03 %
61.17 %
61.17 %
61.17 %
61.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.37 %
3.25 %
2.33 %
1.95 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
23.73 %
27.40 %
31.63 %
32.99 %
Others
16.97 %
14.74 %
8.18 %
4.87 %
3.89 %
No of Share Holders
37
1,248
706
1,261
1,284

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Intimation Of Material Event-High Court Jharkhand Order Civil Litigation Related To Cancer Hospital Land.Mar 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2025
Outcome Of Board Meeting Held On 31St January 2025 And Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Jan 31, 2025
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI Listing Regulations 2015 To Consider And Approve The Unaudited Financial Results For The Quater Ended 31St Dec2025.Jan 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2024
Intimation Of Material Event - Possession & Registry Of Land.Nov 01, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2024
Outcome Of Board Meeting Held On 30Th October, 2024 And Submission Of Unaudited Financial Results For The Half Year Ended 30Th September, 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Oct 30, 2024
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI Listing Regulations, 2015.Oct 22, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public IssueOct 10, 2024
Announcement Regarding Expansion Of Services Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Oct 10, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement) 2015.Oct 07, 2024
Announcement Regarding Grant Of Approval From Pharmacy Council Of India For D. Pharm Course Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,Sep 30, 2024
Closure of Trading WindowSep 26, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 14, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 13, 2024
Intimation Regarding Revision In Credit Rating.Sep 09, 2024
Additional Disclosure As Required Under Regulation 30 Of SEBI (LODR) Regulations,2015.Aug 23, 2024
Reg. 34 (1) Annual Report.Aug 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing ObligationAnd Disclosure Requirement) 2015.Aug 20, 2024
Board Meeting Intimation for BOARD MEETINGAug 13, 2024
Disclosure Of The Impact Of Audit Qualifications On Asarfi Hospital Limited Standalone & Consolidated Financial Statements.Jul 04, 2024
Announcement Under Regulation 30 Of LODR Regulation, 2015 Regarding Board Comment On SDD Non-ComplianceJun 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Jun 19, 2024
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024Jun 13, 2024
IMPACT ON AUDIT QUALIFICATION FOR THE YEAR ENDED 31 MARCH, 2024Jun 13, 2024
Intimation Relating To Disposal Of Appeal Filed (Civil Appeal 6781-6782 / 2023) In Hon'Ble Supreme Court Of India In Favour Of Asarfi Hospital Limited Filed Against The Order Of The Hon'Ble High Court In FA 43 Of 2012 Relating To Land Allotted ByState Of Jharkhand For Establishment Of Cancer Hospital.Jun 06, 2024
Audited Results For 31.03.2024May 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 And Submission OfUnaudited Financial Results For The Half Year And Year Ended 31St March 2024 As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.May 06, 2024
Board Meeting Intimation for Adopting The Unaudited Financial Results For The Half Year And Year Ending 31 March 2024.Apr 29, 2024
Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 29, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 16, 2024
Closure of Trading WindowApr 16, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Issue.Apr 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 11, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Apr 10, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBIMar 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportFeb 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2024
1St Extra Ordinary General Meeting (EGM) Of The Members Of The Company Has Been Scheduled To Be Held On Tuesday, 30Th January 2024 At 12 P.M (Noon), At The Registered Office Of The Company.Dec 30, 2023
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Dec 29, 2023
Submission Of Unaudited Financial Results For The Half Year Ended On 30.09.2023 And Disclosure Pursuant To Regulation 33 Of SEBI (LODR) Regulations, 2015.Nov 13, 2023
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 34 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 13, 2023
Board Meeting Intimation for NOTICE FOR MEETING OF BOARD OF DIRECTORS OF ASARFI HOSPITAL LIMITED TO BE HELD ON TUESDAY, 13TH NOVEMBER 2023 AT 03:00 P.M AT THE REGISTERED OFFICE AT 4TH FLOOR, ASARFI HOSPITAL, BARAMURI, B. POLYTECHNIC, DHANBAD 828130.Nov 06, 2023
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 20, 2023

Technical Indicators

RSI(14)
Neutral
38.18
ATR(14)
Volatile
4.36
STOCH(9,6)
Neutral
48.51
STOCH RSI(14)
Neutral
72.43
MACD(12,26)
Bearish
-0.15
ADX(14)
Strong Trend
27.56
UO(9)
Bearish
42.41
ROC(12)
Downtrend And Accelerating
-3.73
WillR(14)
Neutral
-76.45